123 related articles for article (PubMed ID: 6704544)
1. Elimination of high affinity heparin fractions and their anticoagulant and lipase activity.
de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Verschoor L; Bouma BN; Sixma JJ
Blood; 1984 Apr; 63(4):836-42. PubMed ID: 6704544
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant and lipolytic effects of a low molecular weight heparin fraction.
Harenberg J; Gnasso A; de Vries JX; Zimmermann R; Augustin J
Thromb Res; 1985 Sep; 39(6):683-92. PubMed ID: 4082106
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of intravenously administered heparin in normal humans.
de Swart CA; Nijmeyer B; Roelofs JM; Sixma JJ
Blood; 1982 Dec; 60(6):1251-8. PubMed ID: 7139119
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic studies of standard heparin and low molecular weight heparin in patients with chronic renal failure.
Follea G; Laville M; Pozet N; Dechavanne M
Haemostasis; 1986; 16(2):147-51. PubMed ID: 3710292
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
Harenberg J; Stehle G; Dempfle CE; von Hodenberg E; Heene DL
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):967-80. PubMed ID: 2483715
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment.
Persson E; Nordenström J; Hagenfeldt L; Nilsson-Ehle P
Thromb Res; 1987 Jun; 46(5):697-704. PubMed ID: 3629543
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
Persson E
Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
[TBL] [Abstract][Full Text] [Related]
9. Effect of very low molecular weight heparin-derived oligosaccharides on lipoprotein lipase release in rabbits.
Merchant ZM; Erbe EE; Eddy WP; Patel D; Linhardt RJ
Atherosclerosis; 1986 Nov; 62(2):151-8. PubMed ID: 3801083
[TBL] [Abstract][Full Text] [Related]
10. Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin.
Persson E; Nordenström J; Nilsson-Ehle P; Hagenfeldt L
Eur J Clin Invest; 1985 Aug; 15(4):215-20. PubMed ID: 3930257
[TBL] [Abstract][Full Text] [Related]
11. Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment.
Persson E; Nordenström J; Nilsson-Ehle P
Scand J Clin Lab Invest; 1987 Apr; 47(2):151-5. PubMed ID: 3576117
[TBL] [Abstract][Full Text] [Related]
12. Anti-Xa activity of human hepatic triglyceride lipase.
Gray E; Bengtsson-Olivecrona G; Olivecrona T; Barrowcliffe TW
J Lab Clin Med; 1987 Jun; 109(6):653-9. PubMed ID: 3585139
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of low molecular weight heparin by protamine chloride in vivo.
Harenberg J; Gnasso A; de Vries JX; Zimmermann R; Augustin J
Thromb Res; 1985 Apr; 38(1):11-20. PubMed ID: 4002198
[TBL] [Abstract][Full Text] [Related]
14. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Sixma JJ; Bouma BN
Thromb Haemost; 1984 Aug; 52(1):66-70. PubMed ID: 6495266
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously.
Bergqvist D; Hedner U; Sjörin E; Holmer E
Thromb Res; 1983 Nov; 32(4):381-91. PubMed ID: 6658720
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant activities of high and low molecular weight heparin fractions.
Barrowcliffe TW; Johnson EA; Eggleton CA; Kemball-Cook G; Thomas DP
Br J Haematol; 1979 Apr; 41(4):573-83. PubMed ID: 435404
[TBL] [Abstract][Full Text] [Related]
17. Anti-Xa clotting activities in different hepatic-triglyceride lipase preparations from post-heparin plasma.
Schmidt M; Barrowcliffe TW; Gray E; Watton J; Harenberg J
Thromb Res; 1991 Sep; 63(5):503-8. PubMed ID: 1755003
[TBL] [Abstract][Full Text] [Related]
18. [Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives].
Millot F; Bara L; Etienne J; Samama M; Laruelle P
Nouv Rev Fr Hematol (1978); 1987; 29(6):397-400. PubMed ID: 2837726
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
Shimotori T; Sakuragawa N
Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
[TBL] [Abstract][Full Text] [Related]
20. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
